1-Ethyl-Pyrrolidine-2,5-Dione

Identification

Generic Name
1-Ethyl-Pyrrolidine-2,5-Dione
DrugBank Accession Number
DB01902
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 127.1412
Monoisotopic: 127.063328537
Chemical Formula
C6H9NO2
Synonyms
Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UVesicle-fusing ATPaseNot AvailableHumans
UERO1-like protein betaNot AvailableHumans
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as n-substituted carboxylic acid imides. These are compounds comprising an N-substituted carboxylic acid imide group, with the general structure R1N(C(R2)=O)C(R3)=O (R2,R3=H, alkyl, aryl; R1=Anything but H).
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Carboxylic acids and derivatives
Sub Class
Carboxylic acid derivatives
Direct Parent
N-substituted carboxylic acid imides
Alternative Parents
Pyrrolidine-2-ones / N-alkylpyrrolidines / Dicarboximides / Lactams / Azacyclic compounds / Organopnictogen compounds / Organonitrogen compounds / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds
Substituents
2-pyrrolidone / Aliphatic heteromonocyclic compound / Azacycle / Carbonyl group / Carboxylic acid imide, n-substituted / Dicarboximide / Hydrocarbon derivative / Lactam / N-alkylpyrrolidine / Organic nitrogen compound
Molecular Framework
Aliphatic heteromonocyclic compounds
External Descriptors
pyrrolidinone, dicarboximide (CHEBI:44348) / a small molecule (CPD0-903)
Affected organisms
Not Available

Chemical Identifiers

UNII
MC084H847A
CAS number
Not Available
InChI Key
GHAZCVNUKKZTLG-UHFFFAOYSA-N
InChI
InChI=1S/C6H9NO2/c1-2-7-5(8)3-4-6(7)9/h2-4H2,1H3
IUPAC Name
1-ethylpyrrolidine-2,5-dione
SMILES
CCN1C(=O)CCC1=O

References

General References
Not Available
PubChem Compound
16842
PubChem Substance
46507776
ChemSpider
15961
ChEBI
44348
ZINC
ZINC000001670837
PDBe Ligand
NEN
PDB Entries
1cr5 / 1rp4 / 1rq1 / 2z6b / 3m31 / 3nvj / 4h46 / 4us0 / 6xb1 / 6xb2
show 2 more

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility615.0 mg/mLALOGPS
logP-0.09ALOGPS
logP-0.41Chemaxon
logS0.68ALOGPS
pKa (Strongest Basic)-6.7Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count2Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area37.38 Å2Chemaxon
Rotatable Bond Count1Chemaxon
Refractivity31.93 m3·mol-1Chemaxon
Polarizability12.72 Å3Chemaxon
Number of Rings1Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleYesChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9939
Blood Brain Barrier+0.9982
Caco-2 permeable+0.6294
P-glycoprotein substrateNon-substrate0.71
P-glycoprotein inhibitor INon-inhibitor0.6393
P-glycoprotein inhibitor IINon-inhibitor0.8853
Renal organic cation transporterNon-inhibitor0.589
CYP450 2C9 substrateNon-substrate0.8512
CYP450 2D6 substrateNon-substrate0.7925
CYP450 3A4 substrateSubstrate0.5166
CYP450 1A2 substrateNon-inhibitor0.7889
CYP450 2C9 inhibitorNon-inhibitor0.5905
CYP450 2D6 inhibitorNon-inhibitor0.8644
CYP450 2C19 inhibitorNon-inhibitor0.6697
CYP450 3A4 inhibitorNon-inhibitor0.9618
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9003
Ames testNon AMES toxic0.7895
CarcinogenicityNon-carcinogens0.8844
BiodegradationNot ready biodegradable0.5408
Rat acute toxicity2.1378 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.8498
hERG inhibition (predictor II)Non-inhibitor0.8926
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-004i-1900000000-e555b290061cd50033fe
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-004i-5900000000-ee4dad65387c01a867c2
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-00dl-9200000000-30bdd58921b7f8ec5442
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-224ede0b484bf0b08a3a
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-00di-9000000000-6da1ef99ea4742a14255
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-14728c395b105c603194
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-123.6822275
predicted
DarkChem Lite v0.1.0
[M-H]-123.3384275
predicted
DarkChem Lite v0.1.0
[M-H]-121.518135
predicted
DeepCCS 1.0 (2019)
[M+H]+124.4177275
predicted
DarkChem Lite v0.1.0
[M+H]+124.2025275
predicted
DarkChem Lite v0.1.0
[M+H]+124.413315
predicted
DeepCCS 1.0 (2019)
[M+Na]+124.0251275
predicted
DarkChem Lite v0.1.0
[M+Na]+123.9327275
predicted
DarkChem Lite v0.1.0
[M+Na]+132.99278
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Syntaxin-1 binding
Specific Function
Required for vesicle-mediated transport. Catalyzes the fusion of transport vesicles within the Golgi cisternae. Is also required for transport from the endoplasmic reticulum to the Golgi stack. See...
Gene Name
NSF
Uniprot ID
P46459
Uniprot Name
Vesicle-fusing ATPase
Molecular Weight
82593.645 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
  3. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Unfolded protein binding
Specific Function
Oxidoreductase involved in disulfide bond formation in the endoplasmic reticulum. Efficiently reoxidizes P4HB/PDI, the enzyme catalyzing protein disulfide formation, in order to allow P4HB to susta...
Gene Name
ERO1B
Uniprot ID
Q86YB8
Uniprot Name
ERO1-like protein beta
Molecular Weight
53542.62 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
  3. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52